A Drug-Induced Hybrid Electrospun Poly-Capro-Lactone: Cell-Derived Extracellular Matrix Scaffold for Liver Tissue Engineering

Tissue Engineering - Part A

Volumn 23, Issue 13-14, 2017, Pages 650-662

  Grant, Rhiannon ^a   Hay, David C ^b   Callanan, Anthony ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

3D liver cell culture; acellular biological matrices; drug induced; electrospun scaffolds; Liver tissue engineering

Indexed keywords

CELL CULTURE; CELL ENGINEERING; CELLS; COLLAGEN; CYTOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; ESTERS; GENE EXPRESSION; MECHANICAL TESTING; PATIENT TREATMENT; POLYMERS; TISSUE; TISSUE ENGINEERING;

BIOLOGICAL MATRIXES; DRUG INDUCED; ELECTROSPUN SCAFFOLDS; LIVER CELLS; LIVER TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

ALBUMIN; BUTYRIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DNA; FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LAMININ; MESSENGER RNA; PLASTIC; POLYCAPROLACTONE; VALPROIC ACID; POLYESTER;

ARTICLE; BIOCHEMICAL ANALYSIS; BIOMECHANICS; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL METABOLISM; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ELECTROSPINNING; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF QUANTITATION; LIVER CELL; LIVER TISSUE; PHENOTYPE; PRIORITY JOURNAL; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT; UPREGULATION; CELL LINE; CHEMISTRY; CYTOLOGY; LIVER; METABOLISM; TISSUE SCAFFOLD;

CELL LINE; EXTRACELLULAR MATRIX; HEP G2 CELLS; HUMANS; LIVER; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 85024858284     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2016.0419     Document Type: Article

References (74)

1. NHS Blood and Transplant. Organ donation and transplantation Activity Report 2014-2015. [Epub ahead of print]; DOI: 10.1016/B978-0-12-373932-2.00158-7, 2016.
2. Williams, R., et al. The Lancet commissions addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 384, 1953, 2014.
3. British Association for the Study of the Liver and British Society of Gastroenterology. A time to act: improving liver health and outcomes in liver disease. National Plan Liver Services UK, 2009, pp. 1-52. Available at: http://www.bsg.org.uk/sections/liver-articles/the-national-plan-for-liver-services-uk-2009.html (Accessed April 11, 2017).
4. Muriel, P., and Rivera-Espinoza, Y. Beneficial drugs for liver diseases. J Appl Toxicol 28, 93, 2008.
5. Takebe, T., et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 16, 556, 2015.
6. Takebe, T., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481, 2013.
7. Celiz, A.D., et al. Discovery of a novel polymer for human pluripotent stem cell expansion and multilineage differentiation. Adv Mater [Epub ahead of print]; DOI: 10.1002/adma.201501351, 2015.
8. Villarin, B.L., et al. Polymer supported directed differentiation reveals a unique gene signature predicting stable hepatocyte performance. Adv Healthc Mater [Epub ahead of print]; DOI: 10.1002/adhm.201500391, 2015.
9. Steele, J.A.M., et al. Combinatorial scaffold morphologies for zonal articular cartilage engineering. Acta Biomater 10, 2065, 2014.
10. Chung, S., et al. Responsive poly (g-glutamic acid) fibres for biomedical applications. J Mater Chem B 1, 1397, 2013.
11. Baptista, P.M., Moran, E.C., Vyas, D., et al. Fluid flow regulation of revascularization and cellular organizationin a bioengineered liver platform. Tissue Eng Part C Methods 22, 199, 2016.
12. Palakkan, A.A., et al. Polarisation and functional characterisation of hepatocytes derived from human embryonic and mesenchymal stem cells. Biomed Rep 3, 626, 2015.
13. Sabetkish, S., et al. Whole-organ tissue engineering: de-cellularization and recellularization of three-dimensional matrix liver scaffolds. J Biomed Mater Res A 103, 1498, 2015.
14. Torok, E., et al. Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering. Liver Transplant 13, 465, 2011.
15. Cameron, K., et al. Recombinant laminins drive the differentiation and self-organization of hESC-derived hepa-tocytes. Stem Cell Rep 5, 1, 2015.
16. Szkolnicka, D., Farnworth, S.L., Lucendo-Villarin, B., and Hay, D.C. Deriving functional hepatocytes from pluripotent stem cells. Curr Protoc Stem Cell Biol 30, 1G.5.1, 2014.
17. Hay, D.C., et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA 105, 12301, 2008.
18. He, M., and Callanan, A. Comparison of methods for whole organ decellularisation in tissue engineering of bio-artificial organs. Tissue Eng Part B Rev 19, 194, 2012.
19. De Kock, J., et al. Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bio-engineering tool? Arch Toxicol 85, 607, 2011.
20. Baptista, P.M., et al. The use of whole organ decellular-ization for the generation of a vascularized liver organoid. Hepatology 53, 604, 2011.
21. Barakat, O., et al. Use of decellularized porcine liver for en-gineering humanized liver organ. J Surg Res 173, e11, 2012.
22. Wu, Q., et al. Optimizing perfusion-decellularization methods of porcine livers for clinical-scale whole-organ bioengineering. Biomed Res Int 2015, 1, 2015.
23. Zhou, P., et al. Decellularization and recellularization of rat livers with hepatocytes and endothelial progenitor cells. Artif Organs 40, E25, 2016.
24. He, M., Callanan, A., Lagaras, K., Steele, J.A.M., and Stevens, M.M. Optimization of SDS exposure on preservation of ECM characteristics in whole organ decel-lularization of rat kidneys. J Biomed Mater Res Part B Appl Biomater [Epub ahead of print]; DOI: 10.1002/jbm.b.33668, 2016.
25. Peloso, A., et al. Current achievements and future perspectives in whole-organ bioengineering. Stem Cell Res Ther 6, 107, 2015.
26. Woods, T., and Gratzer, P.F. Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 26, 7339, 2005.
27. Funamoto, S., et al. The use of high-hydrostatic pressure treatment to decellularize blood vessels. Biomaterials 31, 3590, 2010.
28. Cebotari, S., et al. Detergent decellularization of heart valves for tissue engineering: toxicological effects of residual detergents on human endothelial cells. Artif Organs 34, 206, 2010.
29. Naderi, H., Matin, M.M., and Bahrami, A.R. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J Bio-mater Appl 26, 383, 2011.
30. Kim, M.H., et al. Phenotypic regulation of liver cells in a biofunctionalized three-dimensional hydrogel platform. In-tegr Biol [Epub ahead of print]; DOI: 10.1039/C5IB00269A, 2016.
31. Vasanthan, K.S., Sethuraman, S., and Parthasarathy, M. Electrochemical evidence for asialoglycoprotein receptor-mediated hepatocyte adhesion and proliferation in three dimensional tissue engineering scaffolds. Anal Chim Acta 890, 83, 2015.
32. Lee, J.S., et al. Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering. Biomacromolecules 15, 206, 2014.
33. No, D.Y., Jeong, G.S., and Lee, S.-H. Immune-protected xenogeneic bioartificial livers with liver-specific microarchitecture and hydrogel-encapsulated cells. Biomaterials 35, 8983, 2014.
34. Underhill, G.H., Chen, A.A., Albrecht, D.R., and Bhatia, S.N. Assessment of hepatocellular function within PEG hydrogels. Biomaterials 28, 256, 2007.
35. Zeugolis, D.I., et al. Electro-spinning of pure collagen nano-fibres-just an expensive way to make gelatin? Bio-materials 29, 2293, 2008.
36. Dong, B., Arnoult, O., Smith, M.E., and Wnek, G.E. Electrospinning of collagen nanofiber scaffolds from benign solvents. Macromol Rapid Commun 30, 539, 2009.
37. Faulk, D.M., Wildemann, J.D., and Badylak, S.F. Decel-lularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix. J Clin Exp Hepatol 5, 69, 2015.
38. Hotaling, N.A., Bharti, K., Kriel, H., and Simon, C.G. DiameterJ: a validated open source nanofiber diameter measurement tool. Biomaterials 61, 327, 2015.
39. Dokmanovic, M., Clarke, C., and Marks, P.A. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5, 981, 2007.
40. Backliwal, G., et al. Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101, 182, 2008.
41. Yang, W.C., et al. Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers. Mol Biotechnol 56, 421, 2014.
42. Lu, H., Hoshiba, T., Kawazoe, N., and Chen, G. Comparison of decellularization techniques for preparation of extracellular matrix scaffolds derived from three-dimensional cell culture. J Biomed Mater Res A 100, 2507, 2012.
43. Lakes, R. Foam structures with a negative Poisson's ratio. Science 235, 1038, 1987.
44. Greaves, G.N., Greer, A.L., Lakes, R.S., and Rouxel, T. Poisson's ratio and modern materials. Nat Mater 10, 823, 2011.
45. Oliver, W.C., and Pharr, G.M. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments. J Mater Res 7, 1564, 2011.
46. Akhtar, R., et al. Nanoindentation of histological specimens: mapping the elastic properties of soft tissues. J Mater Res 24, 638, 2009.
47. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-AACT method. Methods 25, 402, 2001.
48. Klatt, D., et al. Viscoelastic properties of liver measured by oscillatory rheometry and multifrequency magnetic resonance elastography. Biorheology 47, 133, 2010.
49. Cozzolino, A.M., et al. Modulating the substrate stiffness to manipulate differentiation of resident liver stem cells and to improve the differentiation state of hepatocytes. Stem Cells Int 2016, 5481493, 2016.
50. Mansouri, N. The influence of topography on tissue engineering perspective. Mater Sci Eng C 61, 906, 2016.
51. Davis, N.F., Mooney, R., Callanan, A., Flood, H.D., and McGloughlin, T.M. Augmentation cystoplasty and extracellular matrix scaffolds: an ex vivo comparative study with autogenous detubularised ileum. PLoS One 6, e20323, 2011.
52. Discher, D.E., Janmey, P., and Wang, Y.-L. Tissue cells feel and respond to the stiffness of their substrate. Science 310, 1139, 2005.
53. Martinez-Hernandez, A., and Amenta, P.S. The hepatic ex-tracellular matrix I. Components and distribution in normal liver. Virchows Arch A Pathol Anat Histopathol 423, 1, 1993.
54. Dunn, J.C., Yarmush, M.L., Koebe, H.G., and Tompkins, R.G. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 3, 174, 1989.
55. Martinez-Hernandez, A., and Amenta, P.S. The extracellular matrix in hepatic regeneration. FASEB J 9, 1401, 1995.
56. Carlsson, R., Engvall, E., Freeman, A., and Ruoslahti, E. Laminin and fibronectin in cell adhesion: enhanced adhesion of cells from regenerating liver to laminin. Proc Natl Acad Sci USA 78, 2403, 1981.
57. Matsuzawa, A., Matsusaki, M., and Akashi, M. Construction of three-dimensional liver tissue models by cell accumulation technique and maintaining their metabolic functions for long-term culture without medium change. J Biomed Mater Res A 103, 1554, 2015.
58. Badylak, S.F. The extracellular matrix as a scaffold for tissue reconstruction. Semin. Cell Dev Biol 13, 377, 2002.
59. McCullen, S.D., Autefage, H., Callanan, A., Gentleman, E., and Stevens, M.M. Anisotropic fibrous scaffolds for articular cartilage regeneration. Tissue Eng Part A 18, 2073, 2012.
60. Sell, S.A., et al. The use of natural polymers in tissue engineering: a focus on electrospun extracellular matrix analogues. Polymers (Basel) 2, 522, 2010.
61. Butcher, A.L., Offeddu, G.S., and Oyen, M.L. Nanofibrous hydrogel composites as mechanically robust tissue engineering scaffolds. Trends Biotechnol 32, 564, 2014.
62. Egeblad, M., Rasch, M.G., and Weaver, V.M. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22, 697, 2010.
63. Faulk, D.M., Johnson, S.A., Zhang, L., and Badylak, S.F. Role of the extracellular matrix in whole organ engineering. J Cell Physiol 229, 984, 2014.
64. Crapo, P.M., Gilbert, T.W., and Badylak, S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233, 2011.
65. Hay, D.C., et al. Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 26, 894, 2008.
66. Takebe, T., et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 9, 396, 2014.
67. Broutier, L., et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc 11, 1724, 2016.
68. Li, Q., et al. Proteomic analysis of naturally-sourced biological scaffolds. Biomaterials 75, 37, 2016.
69. Xiang, J., et al. Decellularized spleen matrix for reengineering functional hepatic-like tissue based on bone marrow mesen-chymal stem cells. Organogenesis 12, 128, 2016.
70. Gao, R., et al. Hepatocyte culture in autologous decel-lularized spleen matrix. Organogenesis 11, 16, 2015.
71. Godoy, P., et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87, 1315, 2013.
72. Martinez-Hernandez, A., and Amenta, P.S. The hepatic ex-tracellular matrix II. Ontogenesis, regeneration and cirrhosis. Virchows Arch A Pathol Anat Histopathol 423, 77, 1993.
73. Costantini, S., Di Bernardo, G., Cammarota, M., Castello, G., and Colonna, G. Gene expression signature of human HepG2 cell line. Gene 518, 335, 2013.
74. Chen, G.Y., and Nuñez, G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10, 826, 2010.